Main > ONCOLOGY (**) > Lung>SCLC>ES SCLC > USA. G. CT Induced Neutropenia>



USA. G. CT Induced Neutropenia>'s subsections
(*) CN Approval Date: 2022. 07.13
(*) USA Approval Date: 2021. 02.12.
>CDK4/6 Inhibitor Inj.
>Decrease Prior to Pt/Etoposide or>
CDK: Cyclin-Dependent Kinase
Company
Company Licensee CN
Company Partner USA
ES: Extensive Stage
Generic Name: Trilaciclib
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 19
Patent>UpDate: 2022. 07.12.
TM
TM Web-Site

USA. G. CT Induced Neutropenia>'s products
This section has no products